AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

With the market now full recovered from the tariff-driven selloff, investors should get ready for another double-digit market ...

The loss of Walmart in 2018 and Gap in 2021 were significant blows, as the Walmart credit card program was about 13% of Synchrony’s receivables at the time, and the Gap credit card program was about 5 ...

NervGen Pharma targets a neglected market with significant unmet needs, offering high-risk, high-reward potential if NVG-291 ...

Meta is in talks to quasi-acquire Scale AI to create a new lab for “super-intelligence.” Although Scale AI pitches itself as ...

As the Trump Administration looks for savings in the bloated federal housing complex, the most obvious opportunity is to ...

The recent “Most Favoured Nation” executive order is creating an overhang on biotech stocks and opportunities for selective ...

Consistency, commitment and confidence in your chosen strategy are more critical to your financial success than finding the ...

Any survey of military firearms isn’t complete without also discussing the development of ammunition across this past quarter ...

The Good Kind Of Job Destruction I’m honored to be friends with Joe Lonsdale, co-founder of Palantir and now a storied ...

Create lasting buyer momentum by engaging buyers continuously with thought leadership and a strategic continuum framework.

The search for life beyond Earth is a key driver of modern astronomy and planetary space science. The U.S. is building ...